BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25221363)

  • 1. Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)-Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs-.
    Kobayashi M; Fujinaga Y; Ota H
    Acta Histochem Cytochem; 2014 May; 47(2):45-57. PubMed ID: 25221363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.
    Castellano-Megías VM; Andrés CI; López-Alonso G; Colina-Ruizdelgado F
    World J Gastrointest Oncol; 2014 Sep; 6(9):311-24. PubMed ID: 25232456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.
    Basturk O; Khayyata S; Klimstra DS; Hruban RH; Zamboni G; Coban I; Adsay NV
    Am J Surg Pathol; 2010 Mar; 34(3):364-70. PubMed ID: 20139757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
    Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
    Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
    Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Papillary Mucinous Neoplasms Often Contain Epithelium From Multiple Subtypes and/or Are Unclassifiable.
    Schaberg KB; DiMaio MA; Longacre TA
    Am J Surg Pathol; 2016 Jan; 40(1):44-50. PubMed ID: 26469398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal tubular adenomas (pyloric gland-type) of the pancreas: clinicopathologic features are similar to gastric-type intraductal papillary mucinous neoplasms and different from intraductal tubulopapillary neoplasms.
    Chang X; Jiang Y; Li J; Chen J
    Diagn Pathol; 2014 Sep; 9():172. PubMed ID: 25245835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.
    Omori Y; Ono Y; Kobayashi T; Motoi F; Karasaki H; Mizukami Y; Makino N; Ueno Y; Unno M; Furukawa T
    Virchows Arch; 2020 Jul; 477(1):21-31. PubMed ID: 32291497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm.
    Mamat O; Fukumura Y; Saito T; Takahashi M; Mitomi H; Sai JK; Kawasaki S; Yao T
    Histopathology; 2016 Oct; 69(4):570-81. PubMed ID: 26990132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Distler M; Kersting S; Niedergethmann M; Aust DE; Franz M; Rückert F; Ehehalt F; Pilarsky C; Post S; Saeger HD; Grützmann R
    Ann Surg; 2013 Aug; 258(2):324-30. PubMed ID: 23532107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S; Nakamura A; Horinouchi M; Sato E
    J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.